Porphyria cutanea tarda, C282Y, H63D and S65C HFE gene mutations and hepatitis C infection: A study from Southern France

Dermatology

Volumn 206, Issue 3, 2003, Pages 212-216

  Chiavérini, Christine ^a   Halimi, Gilles ^b   Ouzan, Denis ^c   Halfon, Philippe ^b   Ortonne, Jean Paul ^a   Lacour, Jean Philippe ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

^c INSTITUT ARNAULT TZANCK   (France)

Author keywords

Hepatitis C; HFE mutations; Porphyria cutanea tarda

Indexed keywords

IRON;

ADULT; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; FRANCE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HEALTH STATUS; HEMOCHROMATOSIS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEREDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PATHOGENESIS; PORPHYRIA CUTANEA TARDA; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; STATISTICAL SIGNIFICANCE;

FEMALE; FRANCE; GENOTYPE; HEPATITIS C; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PORPHYRIA CUTANEA TARDA; PREVALENCE; PROSPECTIVE STUDIES;

EID: 0037250325     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068895     Document Type: Article

References (30)

1. Malina M, Stransky J, Zdarsky E: Geographical differences in prevalence of hepatitis C virus infection in PCT. Br J Dermatol 1997; 136:291-292.
2. Sampietro M, Fiorelli G, Fargion S: Iron overload in porphyria cutanea tarda. Haematologica 1999;84:248-253.
3. Feder JN, Gnirke A, Thomas W, Tsuchiashi Z, Ruddy DA, Basava A: A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
4. Mura C, Raguenes O, Férec C: HFE mutation analysis in 711 hemochromatosis probands: Evidence for S65C implication in a mild form of hemochromatosis. Blood 1999;93:2502-2505.
5. Feder JN, Penny DM, Irrinki A, Lee V, Lebron J, Watson N, Tsuchihashi Z, Sigal E, Bjorkman P, Schatzman R: The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 1998;95:1472-1477.
6. Trinder D, Olynyk JK, Sly WS, Morgan EH: Iron uptake from plasma transferrin by the duodenum is impaired in the HFE knockout mouse. Proc Natl Acad Sci 2002;99:5622-5626.
7. Elder GH, Worwood M: Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload. Hepatology 1998;27:181.
8. Roberts AG, Whatley SD, Nicklin S, Worwood M, Pointon J, Stone C, Elder G: The frequency of haemochromatosis associated alleles is increased in British patients with sporadic porphyria cutanea tarda. Hepatology 1997;25: 159-161.
9. Roberts A, Whatley S, Morgan R, Worwood M, Elder G: Increase frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997;349:321-323.
10. Stuart KA, Busfield F, Jazwinska EC, Gibson P, Butterworth L, Cooksley WG, Powell L, Crawford D: The C282Y mutation in the haemochromatosis gene and hepatitis virus infection are independent cofactors for porphyria cutanea tarda in Australian patients. J Hepatol 1998;28:404-409.
11. Martinelli AL, Zago MA, Roselino AM, Filho AB, Villanova MG, Secaf M, Tavella MH, Ramalho LN, Zucoloto S, Franco RF: Porphyria cutanea tarda in Brazilian patients: Association with hemochromatosis C282Y mutation and hepatitis C virus infection. Am J Gastroenterol 2000;95:3516-3521.
12. Sampietro M, Piperno A, Lupica L, Arosio C, Vergani A, Corbetta N, Malosio I, Mattioli M, Fracanzani AL, Cappellini D, Fiorelli G, Fargion S: High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology 1998;27:181-184.
13. Enriquez de Salamanca R, Morales P, Castro M, Rojo R, Gonzalez M, Arnaiz-Villena A: The most frequent HFE allele linked to porphyria cutanea tarda in Mediterraneans is Hi63Asp. Hepatology 1999;30:819-820.
14. Fargion S, Fracanzani AL, Romano R, Cappellini M, Faré M, Mattioli M, Piperno A, Ronchi G, Fiorelli G: Genetic hemochromatosis in Italian patients with porphyria cutanea tarda: Possible explanation for iron overload. J Hepatol 1996;24:564-569.
15. D'Amato M, Macri A, Griso D, Biolcati G, Ameglio F: Are His63Asp or Cys282Tyr HFE mutations associated with porphyria cutanea tarda? Data of patients from central and southern Italy. J Invest Dermatol 1998;111:1242-1243.
16. Dereure O, Aguilar-Martinez P, Bessis D, Perney P, Vallat C, Guillot B, Blanc F, Guilhou JJ: HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: A prospective study of 36 cases from southern France. Br J Dermatol 2001;14:533-539.
17. Lacour JPH, Bodokh I, Castanet J: Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol 1993;128:121-123.
18. Moran MJ, Fontanellas A, Brudieux E, Hombrados I, De Ledingjen V, Couzigou P, De Verneuil H, Enriquez de Salamanca R: Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: The influence of virus C infection. Hepatology 1998; 27:584-589.
19. Chuang T, Brashear R, Lewis C: Porphyria cutanea tarda and hepatitis C virus: A case control study and meta-analysis of the literature. J Am Acad Dermatol 1999;41:31-36.
20. Kazemi-Shirazi L, Datz C, Maier-Dobersberger T, Kaserer K, Hackl F, Polli C, Steindl P, Penner E, Ferenci P: The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 1999;116:127-134.
21. Lamoril J, Andant C, Bogard C, Puy H, Gouya L, Pawlotsky JM, Da Silva V, Soulé JC, Deybach JC, Nordmann Y: Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda. Hepatology 1998;27:848-852.
22. Sampietro M, Fracanzani AL, Corbetta N: High prevalence of hepatitis C virus type 1b in Italian patients with porphyria cutanea tarda. Ital J Gastroenterol Hepatol 1997;29:543-547.
23. Beutler E, Felitti V, Gelbart T, Ho N: The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med 2000;133: 329-337.
24. Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, Obando J, Di Bisceglie A, Tattrie C, Tortorelli K, LeClair P, Mercurio M, Lambrecht R: Porphyria cutanea tarda, hepatitis C, and HFE mutations in North America. Hepatology 1998;27:1661-1669.
25. Roy C, Carlson E, Anderson E, Basava A, Starnes S, Feder J, Enns C: Interaction of the ectodomain of HFE with the transferring receptor are critical for iron homeostasis in cells. FEBS Lett 2000;484; 271-274.
26. Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M, Majorano N, Totaro A, Gasparini P: The gene TRF2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet 2000;25:14-15.
27. Montosi G, Donovan A, Totaro A, Garuti C, Pignatti E, Cassanelli S, Trenor CC, Gasparini P, Andrews NC, Pietrangelo A: Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. J Clin Invest 2001;108:619-623.
28. Dereure O, Esculier C, Aguilar-Martinez P, Dessis D, Guillot B, Guilhou JJ: No evidence of Y250X transferrin receptor type 2 mutation in patients with porphyria cutanea tarda: A study of 38 cases. Dermatology 2002;204:158-159.
29. Martinez PA, Bismuth M, Picot MC, Thelcide C, Pageaux GP, Blanc F, Blanc P, Sched JF, Larrey D: Variable phenotypic presentation of iron overload in H63D homozygotes: Are genetic modifiers the cause? Gut 2001;48:836-842.
30. Townsend A, Drakesmith H: Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease and secondary iron overload. Lancet 2002:359:786-790.